Send your comments and tips to whitecoat@globe.com
  Awards Beth Israel Deaconess Medical Ctr. Boston Medical Center Boston University Brigham and Women's Hospital Broad Institute Cambridge Health Alliance Caritas St. Elizabeth's Medical Ctr. Children's Hospital Boston Dana-Farber Cancer Institute Grants Harvard University Joslin Diabetes Center Lahey Clinic Mass. General Hospital Mass. Health Law McLean Hospital MIT New England Baptist Hospital Personnel Moves Public Health Research Short White Coat Tufts-New England Medical Center Tufts University UMass Memorial Medical Center University of Massachusetts VA Medical Centers    A Healthy Blog Running A Hospital Nature Network Boston SciBos - Corie Lok's blog Kevin, M.D. Blog, MD Nurse at small Dr. Gwenn Is In Healthy Children blog WBUR's CommonHealth Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram &
Gazette.
Boston Globe Health and Science staff:
Scott Allen Alice Dembner Carey Goldberg Liz Kowalczyk Stephen Smith Colin Nickerson Beth Daley Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor. Short White Coat blogger Ishani Ganguli Short White Coat blogger Jennifer Srygley  Week of:
November 11
Week of:
November 4
Week of:
October 28
Week of:
October 21
Week of:
October 14
Week of:
October 7
|
« In case you missed it | Main | Today's Health|Science: DNA unraveled, trolling the genome for cancer clues » Monday, September 24, 2007Today's Globe: anthrax drill, Fernald families, suicide rate as PR
About 80 relatives of Fernald Development Center residents came to express fear that the state would try to close the center, altering the lives of its 180 residents, despite a federal court ruling last month granting residents the right to stay. There is no doubt that many psychiatrists believe that antidepressants, particularly SSRIs like Prozac, Paxil, Zoloft, and Celexa, are helpful in treating depression in adults and adolescents, Alison Bass, a former medical writer for the Globe and author of the upcoming book "Side Effects: A Best-selling Drug on Trial," writes on the op-ed page. But, she asks, who stands to benefit from the latest alarm about an apparent upturn in youth suicide rates? These companies have an enormous stake in reversing the current FDA warnings, she writes. Posted by Elizabeth Cooney at 06:49 AM
|
If yesterday's drill, designed by health and postal authorities to measure how swiftly life-saving medications could be delivered if terrorists seeded the air with 
